Gain Therapeutics Stock Forecast

Sell candidate since Jul 28, 2026 Loss -2.89%

The Gain Therapeutics, Inc. stock price fell by -4.55% on the last day (Friday, 31st Jul 2026) from $1.76 to $1.68. During the last trading day the stock fluctuated 2.68% from a day low at $1.68 to a day high of $1.73. The price has fallen in 6 of the last 10 days and is down by -1.75% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -466 thousand shares and in total, 230 thousand shares were bought and sold for approximately $386.26 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.47% during the next 3 months and, with a 90% probability hold a price between $1.51 and $1.96 at the end of this 3-month period.

GANX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Gain Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.76 and $1.78. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 27, 2026, and so far it has fallen -9.68%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Gain Therapeutics, Inc. stock

Gain Therapeutics, Inc. finds support from accumulated volume at $1.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0450 between high and low, or 2.68%. For the last week the stock has had daily average volatility of 5.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GANX) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Gain Therapeutics, Inc. to open at $1.70, and during the day (based on 14 day Average True Range), to move between $1.62 and $1.74, which gives a possible trading interval of +/-$0.117 (+/-7.24%) up or down from last closing price. If Gain Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.66 (1.19%) than the resistance at $1.82 (8.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Gain Therapeutics, Inc. stock A Buy?

Gain Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.392 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $1.70 ( 0.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk